United States ex rel. Deborah Sheldon v. Allergan Sales, LLC

  1. January 26, 2022

    4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan

    A split Fourth Circuit panel has refused to revive a False Claims Act suit alleging an Allergan unit fraudulently reported drug prices to Medicaid and cost the federal government at least $680 million, finding that the company didn't "knowingly" make false claims.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!